BusinessAbeona Therapeutics Receives Orphan Drug Designation in the European Union for EB-101 Gene Therapy Clinical Trial for Epidermolysis BullosaBy Nasdaq OMXMar 8, 2017, 1:15 PM UTC
BusinessAbeona Therapeutics To Present At The Cowen and Company 37th Annual Health Care ConferenceBy Nasdaq OMXMar 7, 2017, 12:45 PM UTC
BusinessAbeona Therapeutics to Present at Maxim Group LLC Biotech Investor & Partnering Conference in ShanghaiBy Nasdaq OMXMar 3, 2017, 12:44 PM UTC
BusinessAbeona Therapeutics to Present at the 2017 RBC Capital Markets Global Healthcare Conference and 3rd Annual CRISPR CongressBy Nasdaq OMXFeb 21, 2017, 12:48 PM UTC
